SGK
BIO icon

Steigerwald Gordon & Koch’s Bio-Rad Laboratories Class A BIO Stock Holding History

Steigerwald Gordon & Koch’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17K Hold
4
– – ﹤0.01% 720
2026
Q1 		$1.11K Hold
4
– – ﹤0.01% 726
2025
Q4 		$1.21K Hold
4
– – ﹤0.01% 851
2025
Q3 		$1.12K Buy
+4
New +$1.09K ﹤0.01% 756

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Steigerwald Gordon & Koch's BIO Position: Q2 2026 in Review

Steigerwald Gordon & Koch held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 4 shares worth $1.17K. The position accounts for ﹤0.01% of the portfolio, ranked #720.

Steigerwald Gordon & Koch first reported a position in BIO in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.21K in Q4 2025. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Steigerwald Gordon & Koch held 4 shares of Bio-Rad Laboratories Class A worth $1.17K as of Q2 2026.
  • Steigerwald Gordon & Koch left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #720 holding.
  • Steigerwald Gordon & Koch first reported a position in Bio-Rad Laboratories Class A in Q3 2025 and has held it in 4 quarters since.
  • Steigerwald Gordon & Koch's Bio-Rad Laboratories Class A position peaked at $1.21K in Q4 2025.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.